20210419-lab meeting 逸安 | 賴亮全實驗室

Index

00:00 1.
index 1
00:29 2.
Introduction
00:30 3.
Breast cancer (BC)
00:44 4.
Subtypes of breast cancer:
00:49 5.
Breast cancer (BC)
01:15 6.
** after 20210427.pptx
01:26 7.
Subtypes of breast cancer:
02:10 8.
Treatments of breast cancer
03:01 9.
Chemotherapy of triple-negative breast cancer
03:51 10.
Long non-coding RNA (lnc RNA)
04:48 11.
Myc
05:28 12.
Aim of this study
05:44 13.
Slide 10
05:45 14.
Identification of lncRNAs differentially expressed in breast cancer
06:50 15.
Slide 10
06:50 16.
Aim of this study
06:50 17.
Myc
06:51 18.
Long non-coding RNA (lnc RNA)
06:53 19.
Chemotherapy of triple-negative breast cancer
06:57 20.
Long non-coding RNA (lnc RNA)
06:58 21.
Myc
06:59 22.
Aim of this study
06:59 23.
Slide 10
06:59 24.
Identification of lncRNAs differentially expressed in breast cancer
08:11 25.
Slide 12
08:59 26.
Slide 13
09:01 27.
Slide 12
09:38 28.
Slide 13
09:56 29.
Slide 14
11:18 30.
Linc00839 knockdown suppressed cell proliferation and increased sensitivity to paclitaxel in vitro.
12:48 31.
Slide 16
15:50 32.
Slide 17
15:55 33.
Slide 16
15:57 34.
Slide 17
17:44 35.
Linc00839 knockdown inhibited tumor proliferation in vivo.
20:41 36.
Myc activates Linc00839 transcription and regulates its expression level.
21:41 37.
Slide 20
21:43 38.
Myc activates Linc00839 transcription and regulates its expression level.
21:59 39.
Slide 20
25:42 40.
Linc00839 regulates Lin28B and Myc mRNA and protein expression.
31:27 41.
Slide 22
34:39 42.
Slide 23
34:40 43.
Slide 22
35:29 44.
Slide 23
38:30 45.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
40:25 46.
Slide 25
40:28 47.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
41:31 48.
Slide 25
43:09 49.
Slide 26
45:57 50.
Slide 27
45:57 51.
Comment
46:47 52.
** after 20210427.pptx
58:13 53.
Slide 17

Notes (0)

Not logged in or insufficient permissions!

Comment

00:00 1.
index 1
00:29 2.
Introduction
00:30 3.
Breast cancer (BC)
00:44 4.
Subtypes of breast cancer:
00:49 5.
Breast cancer (BC)
01:15 6.
** after 20210427.pptx
01:26 7.
Subtypes of breast cancer:
02:10 8.
Treatments of breast cancer
03:01 9.
Chemotherapy of triple-negative breast cancer
03:51 10.
Long non-coding RNA (lnc RNA)
04:48 11.
Myc
05:28 12.
Aim of this study
05:44 13.
Slide 10
05:45 14.
Identification of lncRNAs differentially expressed in breast cancer
06:50 15.
Slide 10
06:50 16.
Aim of this study
06:50 17.
Myc
06:51 18.
Long non-coding RNA (lnc RNA)
06:53 19.
Chemotherapy of triple-negative breast cancer
06:57 20.
Long non-coding RNA (lnc RNA)
06:58 21.
Myc
06:59 22.
Aim of this study
06:59 23.
Slide 10
06:59 24.
Identification of lncRNAs differentially expressed in breast cancer
08:11 25.
Slide 12
08:59 26.
Slide 13
09:01 27.
Slide 12
09:38 28.
Slide 13
09:56 29.
Slide 14
11:18 30.
Linc00839 knockdown suppressed cell proliferation and increased sensitivity to paclitaxel in vitro.
12:48 31.
Slide 16
15:50 32.
Slide 17
15:55 33.
Slide 16
15:57 34.
Slide 17
17:44 35.
Linc00839 knockdown inhibited tumor proliferation in vivo.
20:41 36.
Myc activates Linc00839 transcription and regulates its expression level.
21:41 37.
Slide 20
21:43 38.
Myc activates Linc00839 transcription and regulates its expression level.
21:59 39.
Slide 20
25:42 40.
Linc00839 regulates Lin28B and Myc mRNA and protein expression.
31:27 41.
Slide 22
34:39 42.
Slide 23
34:40 43.
Slide 22
35:29 44.
Slide 23
38:30 45.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
40:25 46.
Slide 25
40:28 47.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
41:31 48.
Slide 25
43:09 49.
Slide 26
45:57 50.
Slide 27
45:57 51.
Comment
46:47 52.
** after 20210427.pptx
58:13 53.
Slide 17

Share
- Embed URL
- QR code

Index
Notes
Comment
Fullscreen

20210419-lab meeting 逸安

Duration: 58:36, Browse: 779, Last Updated: 2021-04-19

Prev Next

00:00 1.
index 1
00:29 2.
Introduction
00:30 3.
Breast cancer (BC)
00:44 4.
Subtypes of breast cancer:
00:49 5.
Breast cancer (BC)
01:15 6.
** after 20210427.pptx
01:26 7.
Subtypes of breast cancer:
02:10 8.
Treatments of breast cancer
03:01 9.
Chemotherapy of triple-negative breast cancer
03:51 10.
Long non-coding RNA (lnc RNA)
04:48 11.
Myc
05:28 12.
Aim of this study
05:44 13.
Slide 10
05:45 14.
Identification of lncRNAs differentially expressed in breast cancer
06:50 15.
Slide 10
06:50 16.
Aim of this study
06:50 17.
Myc
06:51 18.
Long non-coding RNA (lnc RNA)
06:53 19.
Chemotherapy of triple-negative breast cancer
06:57 20.
Long non-coding RNA (lnc RNA)
06:58 21.
Myc
06:59 22.
Aim of this study
06:59 23.
Slide 10
06:59 24.
Identification of lncRNAs differentially expressed in breast cancer
08:11 25.
Slide 12
08:59 26.
Slide 13
09:01 27.
Slide 12
09:38 28.
Slide 13
09:56 29.
Slide 14
11:18 30.
Linc00839 knockdown suppressed cell proliferation and increased sensitivity to paclitaxel in vitro.
12:48 31.
Slide 16
15:50 32.
Slide 17
15:55 33.
Slide 16
15:57 34.
Slide 17
17:44 35.
Linc00839 knockdown inhibited tumor proliferation in vivo.
20:41 36.
Myc activates Linc00839 transcription and regulates its expression level.
21:41 37.
Slide 20
21:43 38.
Myc activates Linc00839 transcription and regulates its expression level.
21:59 39.
Slide 20
25:42 40.
Linc00839 regulates Lin28B and Myc mRNA and protein expression.
31:27 41.
Slide 22
34:39 42.
Slide 23
34:40 43.
Slide 22
35:29 44.
Slide 23
38:30 45.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
40:25 46.
Slide 25
40:28 47.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
41:31 48.
Slide 25
43:09 49.
Slide 26
45:57 50.
Slide 27
45:57 51.
Comment
46:47 52.
** after 20210427.pptx
58:13 53.
Slide 17

Location

Folder name

2021

Author

陳逸安

Branch

賴亮全教授

Created

2021-04-19 10:46:54

Last Updated

2021-04-19 11:47:40

Duration

58:36